Can a smartphone app help cancer patients fight depression?

NCT ID NCT05012124

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a digital platform could improve collaborative care for depression in cancer patients. About 300 adults receiving cancer treatment with significant depression symptoms were enrolled. The platform aimed to help care managers track symptoms and coordinate treatment more effectively. The trial was terminated early, so its full impact is unknown.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
digital platform for collaborative care management
What this could lead to
If successful, this approach could make depression care more effective and accessible for cancer patients, improving their quality of life during treatment.
What could go wrong
The trial was terminated early, so results are limited. The digital tool may not work better than standard care, and not all patients have reliable internet access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

  • MultiCare Regional Cancer Center - Auburn

    Auburn, Washington, 98002, United States

  • MultiCare Regional Cancer Center - Gig Harbor

    Gig Harbor, Washington, 98335, United States

  • MultiCare Regional Cancer Center - Tacoma

    Tacoma, Washington, 98405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.